Global B-cell lymphoma 2 Inhibitors Market Growth (Status and Outlook) 2025-2031

December 2025 | 71 pages | ID: G152601336CEN
LP Information

Abstracts

According to this study, the global B-cell lymphoma 2 Inhibitors market size will reach US$ million by 2031.

Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.

The symptoms of hematological malignancies are often mild or not apparent, which delays diagnosis and treatment. To overcome this challenge, many organizations such as KNOW AML group and market vendors have been organizing awareness campaigns, which educate patients about the symptoms and available diagnostic methods and treatment options. This factor has increased the sales of various therapeutics, including BCL-2 inhibitors, which is a crucial drug for treating indications such as chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and acute myeloid leukemia (AML). The awareness programs also conduct cancer screening and encourage people to become blood stem cell donors. This will provide significant growth opportunities to market vendors.

LPI (LP Information)' newest research report, the “B-cell lymphoma 2 Inhibitors Industry Forecast” looks at past sales and reviews total world B-cell lymphoma 2 Inhibitors sales in 2024, providing a comprehensive analysis by region and market sector of projected B-cell lymphoma 2 Inhibitors sales for 2025 through 2031. With B-cell lymphoma 2 Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world B-cell lymphoma 2 Inhibitors industry.

This Insight Report provides a comprehensive analysis of the global B-cell lymphoma 2 Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on B-cell lymphoma 2 Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global B-cell lymphoma 2 Inhibitors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for B-cell lymphoma 2 Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global B-cell lymphoma 2 Inhibitors.

This report presents a comprehensive overview, market shares, and growth opportunities of B-cell lymphoma 2 Inhibitors market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Combination Therapy
• Monotherapy

Segmentation by Application:

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma
• Cute Myeloid Leukemia

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AbbVie Inc.
• F. Hoffmann-La Roche Ltd.
• Santa Cruz Biotechnology
• Tocris
• Biovision

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global B-cell lymphoma 2 Inhibitors Market Size (2020-2031)
  2.1.2 B-cell lymphoma 2 Inhibitors Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for B-cell lymphoma 2 Inhibitors by Country/Region (2020, 2024 & 2031)
2.2 B-cell lymphoma 2 Inhibitors Segment by Type
  2.2.1 Combination Therapy
  2.2.2 Monotherapy
2.3 B-cell lymphoma 2 Inhibitors Market Size by Type
  2.3.1 B-cell lymphoma 2 Inhibitors Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global B-cell lymphoma 2 Inhibitors Market Size Market Share by Type (2020-2025)
2.4 B-cell lymphoma 2 Inhibitors Segment by Application
  2.4.1 Chronic Lymphocytic Leukemia
  2.4.2 Small Lymphocytic Lymphoma
  2.4.3 Cute Myeloid Leukemia
2.5 B-cell lymphoma 2 Inhibitors Market Size by Application
  2.5.1 B-cell lymphoma 2 Inhibitors Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global B-cell lymphoma 2 Inhibitors Market Size Market Share by Application (2020-2025)

3 B-CELL LYMPHOMA 2 INHIBITORS MARKET SIZE BY PLAYER

3.1 B-cell lymphoma 2 Inhibitors Market Size Market Share by Player
  3.1.1 Global B-cell lymphoma 2 Inhibitors Revenue by Player (2020-2025)
  3.1.2 Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Player (2020-2025)
3.2 Global B-cell lymphoma 2 Inhibitors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 B-CELL LYMPHOMA 2 INHIBITORS BY REGION

4.1 B-cell lymphoma 2 Inhibitors Market Size by Region (2020-2025)
4.2 Global B-cell lymphoma 2 Inhibitors Annual Revenue by Country/Region (2020-2025)
4.3 Americas B-cell lymphoma 2 Inhibitors Market Size Growth (2020-2025)
4.4 APAC B-cell lymphoma 2 Inhibitors Market Size Growth (2020-2025)
4.5 Europe B-cell lymphoma 2 Inhibitors Market Size Growth (2020-2025)
4.6 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas B-cell lymphoma 2 Inhibitors Market Size by Country (2020-2025)
5.2 Americas B-cell lymphoma 2 Inhibitors Market Size by Type (2020-2025)
5.3 Americas B-cell lymphoma 2 Inhibitors Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC B-cell lymphoma 2 Inhibitors Market Size by Region (2020-2025)
6.2 APAC B-cell lymphoma 2 Inhibitors Market Size by Type (2020-2025)
6.3 APAC B-cell lymphoma 2 Inhibitors Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe B-cell lymphoma 2 Inhibitors Market Size by Country (2020-2025)
7.2 Europe B-cell lymphoma 2 Inhibitors Market Size by Type (2020-2025)
7.3 Europe B-cell lymphoma 2 Inhibitors Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa B-cell lymphoma 2 Inhibitors by Region (2020-2025)
8.2 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Type (2020-2025)
8.3 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL B-CELL LYMPHOMA 2 INHIBITORS MARKET FORECAST

10.1 Global B-cell lymphoma 2 Inhibitors Forecast by Region (2026-2031)
  10.1.1 Global B-cell lymphoma 2 Inhibitors Forecast by Region (2026-2031)
  10.1.2 Americas B-cell lymphoma 2 Inhibitors Forecast
  10.1.3 APAC B-cell lymphoma 2 Inhibitors Forecast
  10.1.4 Europe B-cell lymphoma 2 Inhibitors Forecast
  10.1.5 Middle East & Africa B-cell lymphoma 2 Inhibitors Forecast
10.2 Americas B-cell lymphoma 2 Inhibitors Forecast by Country (2026-2031)
  10.2.1 United States Market B-cell lymphoma 2 Inhibitors Forecast
  10.2.2 Canada Market B-cell lymphoma 2 Inhibitors Forecast
  10.2.3 Mexico Market B-cell lymphoma 2 Inhibitors Forecast
  10.2.4 Brazil Market B-cell lymphoma 2 Inhibitors Forecast
10.3 APAC B-cell lymphoma 2 Inhibitors Forecast by Region (2026-2031)
  10.3.1 China B-cell lymphoma 2 Inhibitors Market Forecast
  10.3.2 Japan Market B-cell lymphoma 2 Inhibitors Forecast
  10.3.3 Korea Market B-cell lymphoma 2 Inhibitors Forecast
  10.3.4 Southeast Asia Market B-cell lymphoma 2 Inhibitors Forecast
  10.3.5 India Market B-cell lymphoma 2 Inhibitors Forecast
  10.3.6 Australia Market B-cell lymphoma 2 Inhibitors Forecast
10.4 Europe B-cell lymphoma 2 Inhibitors Forecast by Country (2026-2031)
  10.4.1 Germany Market B-cell lymphoma 2 Inhibitors Forecast
  10.4.2 France Market B-cell lymphoma 2 Inhibitors Forecast
  10.4.3 UK Market B-cell lymphoma 2 Inhibitors Forecast
  10.4.4 Italy Market B-cell lymphoma 2 Inhibitors Forecast
  10.4.5 Russia Market B-cell lymphoma 2 Inhibitors Forecast
10.5 Middle East & Africa B-cell lymphoma 2 Inhibitors Forecast by Region (2026-2031)
  10.5.1 Egypt Market B-cell lymphoma 2 Inhibitors Forecast
  10.5.2 South Africa Market B-cell lymphoma 2 Inhibitors Forecast
  10.5.3 Israel Market B-cell lymphoma 2 Inhibitors Forecast
  10.5.4 Turkey Market B-cell lymphoma 2 Inhibitors Forecast
10.6 Global B-cell lymphoma 2 Inhibitors Forecast by Type (2026-2031)
10.7 Global B-cell lymphoma 2 Inhibitors Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market B-cell lymphoma 2 Inhibitors Forecast

11 KEY PLAYERS ANALYSIS

11.1 AbbVie Inc.
  11.1.1 AbbVie Inc. Company Information
  11.1.2 AbbVie Inc. B-cell lymphoma 2 Inhibitors Product Offered
  11.1.3 AbbVie Inc. B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AbbVie Inc. Main Business Overview
  11.1.5 AbbVie Inc. Latest Developments
11.2 F. Hoffmann-La Roche Ltd.
  11.2.1 F. Hoffmann-La Roche Ltd. Company Information
  11.2.2 F. Hoffmann-La Roche Ltd. B-cell lymphoma 2 Inhibitors Product Offered
  11.2.3 F. Hoffmann-La Roche Ltd. B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview
  11.2.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.3 Santa Cruz Biotechnology
  11.3.1 Santa Cruz Biotechnology Company Information
  11.3.2 Santa Cruz Biotechnology B-cell lymphoma 2 Inhibitors Product Offered
  11.3.3 Santa Cruz Biotechnology B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Santa Cruz Biotechnology Main Business Overview
  11.3.5 Santa Cruz Biotechnology Latest Developments
11.4 Tocris
  11.4.1 Tocris Company Information
  11.4.2 Tocris B-cell lymphoma 2 Inhibitors Product Offered
  11.4.3 Tocris B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Tocris Main Business Overview
  11.4.5 Tocris Latest Developments
11.5 Biovision
  11.5.1 Biovision Company Information
  11.5.2 Biovision B-cell lymphoma 2 Inhibitors Product Offered
  11.5.3 Biovision B-cell lymphoma 2 Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Biovision Main Business Overview
  11.5.5 Biovision Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. B-cell lymphoma 2 Inhibitors Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. B-cell lymphoma 2 Inhibitors Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Combination Therapy
Table 4. Major Players of Monotherapy
Table 5. B-cell lymphoma 2 Inhibitors Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global B-cell lymphoma 2 Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 7. Global B-cell lymphoma 2 Inhibitors Market Size Market Share by Type (2020-2025)
Table 8. B-cell lymphoma 2 Inhibitors Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global B-cell lymphoma 2 Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 10. Global B-cell lymphoma 2 Inhibitors Market Size Market Share by Application (2020-2025)
Table 11. Global B-cell lymphoma 2 Inhibitors Revenue by Player (2020-2025) & ($ millions)
Table 12. Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Player (2020-2025)
Table 13. B-cell lymphoma 2 Inhibitors Key Players Head office and Products Offered
Table 14. B-cell lymphoma 2 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global B-cell lymphoma 2 Inhibitors Market Size by Region (2020-2025) & ($ millions)
Table 18. Global B-cell lymphoma 2 Inhibitors Market Size Market Share by Region (2020-2025)
Table 19. Global B-cell lymphoma 2 Inhibitors Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas B-cell lymphoma 2 Inhibitors Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas B-cell lymphoma 2 Inhibitors Market Size Market Share by Country (2020-2025)
Table 23. Americas B-cell lymphoma 2 Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas B-cell lymphoma 2 Inhibitors Market Size Market Share by Type (2020-2025)
Table 25. Americas B-cell lymphoma 2 Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas B-cell lymphoma 2 Inhibitors Market Size Market Share by Application (2020-2025)
Table 27. APAC B-cell lymphoma 2 Inhibitors Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC B-cell lymphoma 2 Inhibitors Market Size Market Share by Region (2020-2025)
Table 29. APAC B-cell lymphoma 2 Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC B-cell lymphoma 2 Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe B-cell lymphoma 2 Inhibitors Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe B-cell lymphoma 2 Inhibitors Market Size Market Share by Country (2020-2025)
Table 33. Europe B-cell lymphoma 2 Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe B-cell lymphoma 2 Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of B-cell lymphoma 2 Inhibitors
Table 39. Key Market Challenges & Risks of B-cell lymphoma 2 Inhibitors
Table 40. Key Industry Trends of B-cell lymphoma 2 Inhibitors
Table 41. Global B-cell lymphoma 2 Inhibitors Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global B-cell lymphoma 2 Inhibitors Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global B-cell lymphoma 2 Inhibitors Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global B-cell lymphoma 2 Inhibitors Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. AbbVie Inc. Details, Company Type, B-cell lymphoma 2 Inhibitors Area Served and Its Competitors
Table 46. AbbVie Inc. B-cell lymphoma 2 Inhibitors Product Offered
Table 47. AbbVie Inc. B-cell lymphoma 2 Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. AbbVie Inc. Main Business
Table 49. AbbVie Inc. Latest Developments
Table 50. F. Hoffmann-La Roche Ltd. Details, Company Type, B-cell lymphoma 2 Inhibitors Area Served and Its Competitors
Table 51. F. Hoffmann-La Roche Ltd. B-cell lymphoma 2 Inhibitors Product Offered
Table 52. F. Hoffmann-La Roche Ltd. B-cell lymphoma 2 Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. F. Hoffmann-La Roche Ltd. Main Business
Table 54. F. Hoffmann-La Roche Ltd. Latest Developments
Table 55. Santa Cruz Biotechnology Details, Company Type, B-cell lymphoma 2 Inhibitors Area Served and Its Competitors
Table 56. Santa Cruz Biotechnology B-cell lymphoma 2 Inhibitors Product Offered
Table 57. Santa Cruz Biotechnology B-cell lymphoma 2 Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Santa Cruz Biotechnology Main Business
Table 59. Santa Cruz Biotechnology Latest Developments
Table 60. Tocris Details, Company Type, B-cell lymphoma 2 Inhibitors Area Served and Its Competitors
Table 61. Tocris B-cell lymphoma 2 Inhibitors Product Offered
Table 62. Tocris B-cell lymphoma 2 Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Tocris Main Business
Table 64. Tocris Latest Developments
Table 65. Biovision Details, Company Type, B-cell lymphoma 2 Inhibitors Area Served and Its Competitors
Table 66. Biovision B-cell lymphoma 2 Inhibitors Product Offered
Table 67. Biovision B-cell lymphoma 2 Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Biovision Main Business
Table 69. Biovision Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. B-cell lymphoma 2 Inhibitors Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global B-cell lymphoma 2 Inhibitors Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. B-cell lymphoma 2 Inhibitors Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. B-cell lymphoma 2 Inhibitors Sales Market Share by Country/Region (2024)
Figure 8. B-cell lymphoma 2 Inhibitors Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global B-cell lymphoma 2 Inhibitors Market Size Market Share by Type in 2024
Figure 10. B-cell lymphoma 2 Inhibitors in Chronic Lymphocytic Leukemia
Figure 11. Global B-cell lymphoma 2 Inhibitors Market: Chronic Lymphocytic Leukemia (2020-2025) & ($ millions)
Figure 12. B-cell lymphoma 2 Inhibitors in Small Lymphocytic Lymphoma
Figure 13. Global B-cell lymphoma 2 Inhibitors Market: Small Lymphocytic Lymphoma (2020-2025) & ($ millions)
Figure 14. B-cell lymphoma 2 Inhibitors in Cute Myeloid Leukemia
Figure 15. Global B-cell lymphoma 2 Inhibitors Market: Cute Myeloid Leukemia (2020-2025) & ($ millions)
Figure 16. Global B-cell lymphoma 2 Inhibitors Market Size Market Share by Application in 2024
Figure 17. Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Player in 2024
Figure 18. Global B-cell lymphoma 2 Inhibitors Market Size Market Share by Region (2020-2025)
Figure 19. Americas B-cell lymphoma 2 Inhibitors Market Size 2020-2025 ($ millions)
Figure 20. APAC B-cell lymphoma 2 Inhibitors Market Size 2020-2025 ($ millions)
Figure 21. Europe B-cell lymphoma 2 Inhibitors Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size 2020-2025 ($ millions)
Figure 23. Americas B-cell lymphoma 2 Inhibitors Value Market Share by Country in 2024
Figure 24. United States B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC B-cell lymphoma 2 Inhibitors Market Size Market Share by Region in 2024
Figure 29. APAC B-cell lymphoma 2 Inhibitors Market Size Market Share by Type (2020-2025)
Figure 30. APAC B-cell lymphoma 2 Inhibitors Market Size Market Share by Application (2020-2025)
Figure 31. China B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 35. India B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe B-cell lymphoma 2 Inhibitors Market Size Market Share by Country in 2024
Figure 38. Europe B-cell lymphoma 2 Inhibitors Market Size Market Share by Type (2020-2025)
Figure 39. Europe B-cell lymphoma 2 Inhibitors Market Size Market Share by Application (2020-2025)
Figure 40. Germany B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 41. France B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 42. UK B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size Market Share by Application (2020-2025)
Figure 48. Egypt B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries B-cell lymphoma 2 Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 54. APAC B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 55. Europe B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 57. United States B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 58. Canada B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 59. Mexico B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 60. Brazil B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 61. China B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 62. Japan B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 63. Korea B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 65. India B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 66. Australia B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 67. Germany B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 68. France B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 69. UK B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 70. Italy B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 71. Russia B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 72. Egypt B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 73. South Africa B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 74. Israel B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 75. Turkey B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)
Figure 76. Global B-cell lymphoma 2 Inhibitors Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global B-cell lymphoma 2 Inhibitors Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries B-cell lymphoma 2 Inhibitors Market Size 2026-2031 ($ millions)